REQUEST A DEMO
Total
USD $0.00
Search more companies

Alphamab Oncology (康宁杰瑞生物制药) (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Alphamab Oncology Profile Updated: December 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Alphamab Oncology (康宁杰瑞生物制药) is an enterprise based in Hong Kong SAR, China. Its main office is in Suzhou. It operates in the Pharmaceutical and Medicine Manufacturing sector. It was first established on April 01, 2026. It currently has a total number of 420 (2024) employees. There was a net sales revenue increase of 81.42% reported in Alphamab Oncology (康宁杰瑞生物制药)’s latest financial highlights for Q2C2025. There was a total growth of 10.22% in Alphamab Oncology (康宁杰瑞生物制药)’s total assets over the same period.

Headquarters
No. 175 Fangzhou Road, Suzhou Industrial Park, Suzhou
Suzhou; Jiangsu;

Contact Details: Purchase the Alphamab Oncology (康宁杰瑞生物制药) report to view the information.

Website: http://www.alphamabonc.com

Basic Information
Total Employees:
Purchase the Alphamab Oncology (康宁杰瑞生物制药) report to view the information.
Outstanding Shares:
Purchase the Alphamab Oncology (康宁杰瑞生物制药) report to view the information.
Registered Capital:
Purchase the Alphamab Oncology (康宁杰瑞生物制药) report to view the information.
Financial Auditors:
Purchase the Alphamab Oncology (康宁杰瑞生物制药) report to view the information.
Incorporation Date:
April 01, 2026
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
32.54%
Purchase this report to view the information.
8.88%
Purchase this report to view the information.
8.88%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Alphamab Oncology (Bvi) Ltd. (United Kingdom)
100%
Company Performance
Financial values in the chart are available after Alphamab Oncology (康宁杰瑞生物制药) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HKD. Absolute financial data is included in the purchased report.
Net sales revenue
81.42%
Total Operating Revenue
76.05%
Operating Profit
N/A
EBITDA
N/A
Net Profit/Loss for the Period
N/A
Total Assets
10.22%
Total Equity
13.99%
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
-6134%
Quick Ratio
290.13%
Cash Ratio
-1.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?